Methods and models for assessing efficacy of immunotherapies
US12409237B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 28, 2024 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Jun 28, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0331
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of identifying anti-tumor activity of a test substance is provided along with a genetically-modified, immunodeficient mouse and methods of use, wherein the genetically-modified, immunodeficient mouse enables in vivo investigation of the interactions between the human immune system and human cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.